| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/1997 | EP0447483B1 Dopamine receptors and genes |
| 06/18/1997 | CN1152338A Streptogramines and method for preparing same by mutasynthesis |
| 06/18/1997 | CN1152314A New agonist compounds |
| 06/18/1997 | CN1152313A Process for preparation of 2-(1-azabicyclo(2,2,2)oct-3-yl)-2,4,5,6-tetrahydro-1H-benz (DE)isoquinolin-1-1one and intermediate product |
| 06/18/1997 | CN1152312A New azolidinediones as antihyperglycemic agents |
| 06/18/1997 | CN1152311A Anti-helicobacter acyl derivatives of azolones |
| 06/18/1997 | CN1152310A Anti-helicobacter heterocyclic derivatives of azolines |
| 06/18/1997 | CN1152309A Anti-helicobacter urea and thiourea derivatives of azolones |
| 06/18/1997 | CN1152308A Sulfonamide derivatives of azolones anti-helicobacter agents |
| 06/18/1997 | CN1152304A Substituted benzamidines, their production and their use as medicaments |
| 06/18/1997 | CN1152303A Novel chemical compound, its preparation and use as drug |
| 06/18/1997 | CN1152302A Retinoic acid X-receptor ligands |
| 06/18/1997 | CN1152259A Use of thioketene derivatives for preventing or treating hepatitis B |
| 06/18/1997 | CN1152254A Therapeutic food composition and method to diminish blood sugar fluctuations |
| 06/18/1997 | CN1152253A Two-and three-component fungicidal mixtures |
| 06/18/1997 | CN1151989A 2-(aminomethyl)-3,4,7,-9-tetrahydro-2H-pyrano-£2,3-e| indol-8-ones and derivatives |
| 06/18/1997 | CN1151986A N-methyl-n-£(1s)-1-phenyl-2-((3s)-3-hydroxypyrrolidin-1-yl) ethyl-2,2-diphenylacetamide |
| 06/18/1997 | CN1151893A Combination antiemetic therapy using NK-1 receptor antagonists |
| 06/18/1997 | CN1151866A External therapeutic composition for dermatitis |
| 06/18/1997 | CN1151865A Cancer chemopreventive agent |
| 06/18/1997 | CN1151864A Beta-carotin microcapsule powder and its prepn |
| 06/18/1997 | CN1151863A Mixed skin absorbent |
| 06/18/1997 | CN1035181C Process for prep. of 3-unsaturated alkyl cephems from 3-triflyl cepheme |
| 06/18/1997 | CN1035180C Prep. of Macrolide antibiotics |
| 06/18/1997 | CN1035179C New indol derivatives |
| 06/18/1997 | CN1035177C Prep. of 20-methyl-substituted vitamin D-derivatives |
| 06/17/1997 | US5639913 Treatment of parkinson's disease, dementia, epilepsy |
| 06/17/1997 | US5639904 Cardiovascular disorders |
| 06/17/1997 | US5639902 (Cyclohexyl)alkene compounds |
| 06/17/1997 | US5639892 Memory enhancing and analgesic 1,2,3,3a,8,8a,-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b] indoles |
| 06/17/1997 | US5639887 MDR reversal agents |
| 06/17/1997 | US5639886 One-pot process for the preparation of 3-quinolonecarboxylic acid derivatives |
| 06/17/1997 | US5639884 Antitumor agents |
| 06/17/1997 | US5639882 2-substituted tertiary carbinol derivatives of 1,5-iminosugars |
| 06/17/1997 | US5639881 Synthesis and elucidation of pyrimido (4,5-Q) quinazoline derivatives |
| 06/17/1997 | US5639876 Encoding protein capable of selectively binding to immune serum which inhibits helminth development |
| 06/17/1997 | US5639873 Oligothionucleotides |
| 06/17/1997 | US5639872 Human VEGF-specific oligonucleotides |
| 06/17/1997 | US5639796 Injectable medical composition and method of use |
| 06/17/1997 | US5639792 No synthetase inhibitors as medicinal products intended to reduce alcohol consumption or to prevent excessive alcohol consumption |
| 06/17/1997 | US5639789 Antithrombotic drugs |
| 06/17/1997 | US5639787 Administering ascorbic acid |
| 06/17/1997 | US5639785 Administering substituted 3-phenylchromenes to promote conversion of gray hair to original color |
| 06/17/1997 | US5639784 Administering 3-amino-5-carbamoyl-chromenes and derivatives |
| 06/17/1997 | US5639783 Ketone derivatives |
| 06/17/1997 | US5639782 Antiinflammatory agent; antiallergens |
| 06/17/1997 | US5639781 Alcohol or aldehyde derivatives and their use |
| 06/17/1997 | US5639779 Treatment of different types of headaches |
| 06/17/1997 | US5639778 Indoletetralins having dopaminergic activity |
| 06/17/1997 | US5639777 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders |
| 06/17/1997 | US5639775 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H3 -receptor antagonists and therapeutic uses thereof |
| 06/17/1997 | US5639773 Ocular hypotensive agent |
| 06/17/1997 | US5639772 Administering 3-amino-5-carbamoyl-chromenes and derivatives for treatment of 5-hydroxytryptamine mediated disorders of central nervous system |
| 06/17/1997 | US5639769 Administering antiviral agent |
| 06/17/1997 | US5639768 Leukototriene receptor antagonist; antinflammatory agents |
| 06/17/1997 | US5639767 Topically applying l-carnitine ester to skin |
| 06/17/1997 | US5639766 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 06/17/1997 | US5639765 Guanidinoalkyl glycine β-amino acids useful for inhibiting bone loss |
| 06/17/1997 | US5639764 2-[(4-heteroaryl)-1-piperidinyl)alkyl]-1,3-indandiones and related compound and their therapeutic utility |
| 06/17/1997 | US5639761 Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof |
| 06/17/1997 | US5639760 Useful as muscle relaxants, sedatives, anxiolytics, anticonvulsants, and antidotes for drug overdose |
| 06/17/1997 | US5639759 Organ transplantation; autoimmune diseases, antiinflammatory agents; skin disorders; antiarthritic agents; anticancer agents |
| 06/17/1997 | US5639758 Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 06/17/1997 | US5639757 Treating cancer, atherosclerosis, transplant rejection, rheumatoid arthritis, psoriasis or angiogenesis-related diseases |
| 06/17/1997 | US5639756 Antidiabetic agents |
| 06/17/1997 | US5639755 Methods of combatting infectious diseases using dicationic bis-benzimidazoles |
| 06/17/1997 | US5639754 Bactericides treating helicobacter infection |
| 06/17/1997 | US5639752 Serotonin agonist |
| 06/17/1997 | US5639750 Administering platelet activating factor antagonists |
| 06/17/1997 | US5639749 Inhibitors of glycinamide ribonucleotide formyl transferase; antitumor agents |
| 06/17/1997 | US5639747 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/17/1997 | US5639746 Inhibitors of metalloprotease |
| 06/17/1997 | US5639745 Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors |
| 06/17/1997 | US5639742 Antibiotic; bactericide |
| 06/17/1997 | US5639741 Steroids treating skin disorders |
| 06/17/1997 | US5639740 Mixture of lecithin, isopropyl palmitate and water |
| 06/17/1997 | US5639738 Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| 06/17/1997 | US5639737 Method and compositions for treating malignant tumors and inhibiting growth and metastases of malignant tumors |
| 06/17/1997 | US5639736 Reducing neovascularization by administering through the eye |
| 06/17/1997 | US5639735 Antitumor antibiotic compounds: hayumicins and analogs thereof |
| 06/17/1997 | US5639712 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
| 06/17/1997 | US5639653 Method for proliferating Vγ2Vδ2 T cells |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639595 Identification of novel drugs and reagents |
| 06/17/1997 | US5639478 Method to stabilize a pharmaceutical composition and its production |
| 06/17/1997 | US5639472 Percutaneous absorption preparation |
| 06/17/1997 | US5639469 Transmucosal delivery system |
| 06/17/1997 | US5639468 Applying mixtures of manoalides and drug carriers to surfaces of organs or tissues before closing surgical incisions |
| 06/17/1997 | US5639452 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2192738A1 Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/14/1997 | CA2165141A1 Use of suleparoide in the prevention of endothelitis and other endothelial reactions induced by therapeutic intravenous infusions |
| 06/13/1997 | CA2192518A1 Method for reducing infarct size in subjects afflicted with ischemic heart disease |
| 06/12/1997 | WO1997021104A1 Method of diagnosing and treating epithelioma |
| 06/12/1997 | WO1997021103A1 Treatment and diagnosis of infections due to helicobacter pylori |
| 06/12/1997 | WO1997021100A1 Hiv protease inhibitors |
| 06/12/1997 | WO1997020940A1 Compositions and method for stimulating antibody release by b lymphocytes |